Description

Zemplar -Drug Insights, 2016

DelveInsight Drug Report, “Zemplar- Drug Insights, 2016” highlights the Zemplar marketed details, pipeline status and the Global API Manufacturers along with the location. The DelveInsight’s report covers the Global Market Assessment of the Zemplar covering the total sales estimation and also provides the Zemplar sales performance during the historical period and forecast period to 2018. DelveInsight’s Report also covers the detailed clinical assessment of Zemplar, patents information and exclusivity data, route of synthesis, competitive landscape, and generic players. In addition to this, DelveInsight’s Report provides the SWOT analysis for the Zemplar.

Please note:This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated drug.Scope

A review of the Zemplar based on information derived from company and industry-specific sourcesCoverage of the Marketed data of the Zemplar on the basis of MOA, target, dosage, route of administration, molecule type, strength, Chemical type and ATC ClassificationCoverage of the United States Drug Master File (US DMF), Active Substance Master File/EU DMF and API Manufactures in China & India for Zemplar with location detailsPatent Expiry Timeline and Exclusivity DetailsRoute of Synthesis of the APIGlobal Forecasted Sales Figure to 2018Qualitative and quantitative assessment of market spaceSWOT AnalysisReasons to buy

Evaluate the marketing status and exclusivity details of Zemplar to exploit opportunities for generic drug development opportunities.Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to Zemplar.API intelligence over Zemplar and gaining primary intelligence over Active Ingredients manufacturers across the globe.Understanding the chemical route of synthesis of Zemplar.Uncovering opportunities in the rapidly growing the US marketStay ahead of competition by understanding the changing competitive landscapeEffectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potentialMake more informed business decisions from insightful and in-depth analysis of the drug’s performanceObtain sales forecast for currently marketed drug for to 2018